Insights

Innovative Immunotherapy Imvax specializes in personalized tumor-derived immunotherapies, creating tailored treatments for challenging solid tumors such as glioblastoma. This unique approach offers opportunities to collaborate with pharmaceutical companies seeking advanced oncology solutions.

Recent Funding & Growth With recent investments totaling $52M and ongoing clinical trials, Imvax is expanding its research and development capabilities, opening doors for partnerships in clinical trial services, manufacturing, and bioprocessing technologies.

Technological Edge Utilizing a modern tech stack including Looker, MySQL, and Veeva Vault, Imvax demonstrates a commitment to data-driven decision making and compliance, indicating potential needs for enterprise software solutions, data analytics, and integration services.

Market Focus Focusing on aggressive and difficult-to-treat cancers like glioblastoma, Imvax presents an opportunity to supply specialized medical devices, diagnostic tools, or adjunct therapies targeting high unmet medical needs within oncology.

Leadership & Expansion Strategic hires and leadership appointments signal growth and new strategic directions, suggesting potential collaborations in leadership development, HR solutions, and corporate advisory services to support their expansion plans.

Imvax, Inc. Tech Stack

Imvax, Inc. uses 8 technology products and services including Looker, Microsoft Visio, Microsoft 365, and more. Explore Imvax, Inc.'s tech stack below.

Looker

Analytics

Microsoft Visio

Dev Tools

Microsoft 365

Veeva Vault

Enterprise Content Management

Microsoft Office

Office Suites

Google Tag Manager

Tag Management

GoDaddy

Web Hosting

MonsterInsights

Web Platform Extensions

Imvax, Inc. Email Formats	Example	Percentage
F.Last@imvax.com	J.Doe@imvax.com	52%
First.Last@imvax.com	John.Doe@imvax.com	25%
First@imvax.com	John@imvax.com	20%
FLast@imvax.com	JDoe@imvax.com	3%

Imvax, Inc. Email Formats

Example

Percentage

F.Last@imvax.com

J.Doe@imvax.com

52%

First.Last@imvax.com

John.Doe@imvax.com

25%

First@imvax.com

John@imvax.com

20%

FLast@imvax.com

JDoe@imvax.com

Frequently Asked Questions

Where is Imvax, Inc.'s headquarters located?

Imvax, Inc.'s main headquarters is located at 601 Walnut Street Philadelphia, Pennsylvania 19106 United States. The company has employees across 1 continents, including North America.

What is Imvax, Inc.'s official website and social media links?

Imvax, Inc.'s official website is imvax.com and has social profiles on LinkedIn Crunchbase.

What is Imvax, Inc.'s SIC code NAICS code?

Imvax, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Imvax, Inc. have currently?

As of June 2026, Imvax, Inc. has approximately 25 employees across 1 continents, including North America. Key team members include Cmo: D. A.Chief Operating Officer: S. H.Chief Financial Officer And Chief Legal Officer: J. L.. Explore Imvax, Inc.'s employee directory with LeadIQ.

What industry does Imvax, Inc. belong to?

Imvax, Inc. operates in the Biotechnology Research industry.

What technology does Imvax, Inc. use?

Imvax, Inc.'s tech stack includes LookerMicrosoft VisioMicrosoft 365Veeva VaultMicrosoft OfficeGoogle Tag ManagerGoDaddyMonsterInsights.

What is Imvax, Inc.'s email format?

Imvax, Inc.'s email format typically follows the pattern of F.Last@imvax.com. Find more Imvax, Inc. email formats with LeadIQ.

How much funding has Imvax, Inc. raised to date?

As of June 2026, Imvax, Inc. has raised $29M in funding. The last funding round occurred on Jan 29, 2025 for $29M.

When was Imvax, Inc. founded?

Imvax, Inc. was founded in 2015.

Imvax, Inc.

Q: What is Imvax, Inc.'s official website and social media links?

Imvax, Inc.'s official website is imvax.com. Imvax, Inc. has social profiles on LinkedIn.

Q: How many employees does Imvax, Inc. have currently?

Imvax, Inc. has approximately 25 employees.

Q: What technology does Imvax, Inc. use?

Imvax, Inc.'s tech stack includes Microsoft Visio, MonsterInsights, jQuery Migrate, Microsoft SharePoint, Autoptimize.

Q: What is Imvax, Inc.'s NAICS code?

Imvax, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchPennsylvania, United States11-50 Employees

Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies. Imvax’s combination therapy uniquely captures the complete antigenic signature of a patient’s own tumor and converts it into a highly stimulatory ‘training program’ for the patient’s immune system. The comprehensive nature of this training is intended to result in both innate and adaptive immune stimulation to optimize long-term anti-tumor effects.

The company’s lead program is in glioblastoma multiforme (GBM), an extremely aggressive form of brain cancer, with additional programs in other types of solid tumors.

Insights

Similar companies to Imvax, Inc.

Roche

Johnson & Johnson

Merck

Moderna

Pfizer

AstraZeneca

Gilead Sciences

Novartis

Imvax, Inc. Tech Stack

Media & News

Imvax, Inc. received financing of $29M in financing round on Jan 29th '25.

Imvax, Inc. is developing Goldspire.

Imvax, Inc. hires Stephen Webster as board of directors.

Imvax, Inc. received financing of $23M in financing round on Sep 6th '23.

Imvax, Inc. launches Journal for ImmunoTherapy of Cancer showing IGV-001 can induce clinically relevant anti-cancer immune responses in glioblastoma via immunogenic Cell death.

Imvax, Inc. hired John M. Limongelli as Chief Legal Officer on Sep 16th '21.

Imvax, Inc. hired Josh Muntner as chief financial officer on Aug 31st '21.

Imvax, Inc.'s Email Address Formats